HI
NVAX icon

Harbour Investments’s Novavax NVAX Stock Holding History

Harbour Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Sell
120
-10
-8% -$90 ﹤0.01% 4188
2026
Q1 		$1.06K Buy
130
+45
+53% +$408 ﹤0.01% 4089
2025
Q4 		$571 Hold
85
– – ﹤0.01% 3536
2025
Q3 		$737 Hold
85
– – ﹤0.01% 3459
2025
Q2 		$536 Hold
85
– – ﹤0.01% 3363
2025
Q1 		$545 Sell
85
-35
-29% -$289 ﹤0.01% 3329
2024
Q4 		$965 Hold
120
– – ﹤0.01% 3178
2024
Q3 		$1.52K Hold
120
– – ﹤0.01% 3007
2024
Q2 		$1.52K Hold
120
– – ﹤0.01% 2888
2024
Q1 		$574 Hold
120
– – ﹤0.01% 3011
2023
Q4 		$576 Sell
120
-120
-50% -$735 ﹤0.01% 2905
2023
Q3 		$1.74K Hold
240
– – ﹤0.01% 2586
2023
Q2 		$1.78K Hold
240
– – ﹤0.01% 2575
2023
Q1 		$1.66K Sell
240
-20
-8% -$184 ﹤0.01% 2598
2022
Q4 		$2.67K Sell
260
-182
-41% -$3.21K ﹤0.01% 2445
2022
Q3 		$23K Hold
442
– – ﹤0.01% 1583
2022
Q2 		$23K Buy
+442
New +$22.9K ﹤0.01% 1583
2021
Q4 		$51K Sell
357
-1,783
-83% -$306K ﹤0.01% 1254
2021
Q3 		$444K Buy
2,140
+188
+10% +$41.4K 0.01% 685
2021
Q2 		$414K Sell
1,952
-127
-6% -$23.3K 0.01% 752
2021
Q1 		$377K Buy
+2,079
New +$414K 0.01% 721

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Harbour Investments's NVAX Position: Q2 2026 in Review

Harbour Investments reduced its Novavax (NVAX) stake by 7.7% in Q2 2026, selling an estimated $90 and leaving 120 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4188.

Harbour Investments first reported a position in NVAX in Q1 2021 and has held it in 21 quarters since. The position peaked at $444K in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Harbour Investments held 120 shares of Novavax worth $1.13K as of Q2 2026.
  • Harbour Investments sold 10 Novavax shares in Q2 2026, an estimated $90.
  • Novavax made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4188 holding.
  • Harbour Investments first reported a position in Novavax in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Novavax position peaked at $444K in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.